About GABA Therapeutics
GABA Therapeutics is a private company based in Newport Beach, California, incorporated in 2019 in Delaware. It has reported $22,000,000 raised in two offerings on Form D since October 2019. Its chief executive is Mario Saltarelli.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 26, 2023 | Oct 10, 2023 | $500,000of $1.0M target | 3 | $166K | Equity, Simple Agreements for Future Equity (SAFEs)Rule 506(b) | Form D ↗ |
| Aug 29, 2019 | Oct 18, 2019 | $21,500,000target not set | 2 | $10.7M | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, two offerings | $22,000,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on GABA Therapeutics's Form D filed Oct 10, 2023.
RB
Ryan Barrett
Director
First appears on the Form D that GABA Therapeutics filed on October 10, 2023; on 1 of its 2 filings.
HF
H. Fibiger
Director
First appears on the Form D that GABA Therapeutics filed on October 10, 2023; on 1 of its 2 filings.
SR
Srinivas Rao
Director
First appears on the Form D that GABA Therapeutics filed on October 10, 2023; on 1 of its 2 filings.
MS
Mario Saltarelli
Chief Executive Officer and director
First appears on the Form D that GABA Therapeutics filed on October 10, 2023; on 1 of its 2 filings.
RF
Richard Farrell
Executive officer and director
On every Form D that GABA Therapeutics has filed: 2 filings, from Oct 18, 2019 to Oct 10, 2023.
Earlier filings also listed
- Olivier Dasse · executive officerLast listed on the Form D that GABA Therapeutics filed on October 18, 2019; on 1 of its 2 filings.
- Matthias Luz · directorLast listed on the Form D that GABA Therapeutics filed on October 18, 2019; on 1 of its 2 filings.
- Ian Massey · executive officer and directorLast listed on the Form D that GABA Therapeutics filed on October 18, 2019; on 1 of its 2 filings.
- Florian Brand · directorLast listed on the Form D that GABA Therapeutics filed on October 18, 2019; on 1 of its 2 filings.
- David Putman · executive officerLast listed on the Form D that GABA Therapeutics filed on October 18, 2019; on 1 of its 2 filings.
- Christian Fibiger · directorLast listed on the Form D that GABA Therapeutics filed on October 18, 2019; on 1 of its 2 filings.